Dr. Samir R. Kapadia, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 241
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
OH license 35070511K
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cleveland Clinic Cleveland, OH
- Hillcrest Hospital Mayfield Heights, OH
- Mercy Medical Center Canton, OH
Medical groups
- Cleveland Clinic (7,090 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 241
- Services billed
- 468
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 58 | 53 |
| Established patient office or other outpatient visit, 30-39 minutes | 57 | 57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | 50 |
| Replacement of aortic valve through the skin and femoral artery | 42 | 41 |
| Placement and subsequent removal of device to protect brain from embolism through catheter using imaging guidance | 28 | 28 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 27 | 26 |
| New patient office or other outpatient visit, 60-74 minutes | 26 | 26 |
| New patient office or other outpatient visit, 45-59 minutes | 25 | 25 |
| Repair of mitral valve through the skin, initial prosthesis | 25 | 25 |
| Repair of valve between upper right and lower right chambers of heart (tricuspid valve) using prosthesis delivered via catheter, accessed through skin; initial prosthesis | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Cleveland, OH | 67 |
| Eliquis (apixaban) Other prescribers in Cleveland, OH | 64 |
| Metoprolol Succinate Other prescribers in Cleveland, OH | 61 |
| Jardiance (empagliflozin) Other prescribers in Cleveland, OH | 60 |
| Atorvastatin Calcium Other prescribers in Cleveland, OH | 51 |
| Losartan Potassium Other prescribers in Cleveland, OH | 30 |
| Furosemide Other prescribers in Cleveland, OH | 24 |
| Rosuvastatin Calcium Other prescribers in Cleveland, OH | 22 |
| Amlodipine Besylate Other prescribers in Cleveland, OH | 22 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Cleveland, OH | 20 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 8 payments worth $639 in total to this clinician.
| Abbott Laboratories | $594 |
|---|---|
| Argon Medical Devices, Inc. | $23.04 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $22.17 |
| Travel and Lodging | $361 |
|---|---|
| Food and Beverage | $278 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Nov 18, 2025 | Travel and Lodging MITRACLIP · Structural Heart · travel to San Fancisco, CA · in-kind | $352 |
| Abbott Laboratories Nov 18, 2025 | Travel and Lodging MITRACLIP · Structural Heart · travel to San Fancisco, CA · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 14 industry-funded studies in 2025, from 3 companies. The companies reported $1,122,921 in research payments for these studies, mostly to the institutions running them.
- THE ENCIRCLE Trial (#2018-19)
Edwards Lifesciences Corporation - Partner3 2015-08
Edwards Lifesciences Corporation - NCT03904147--TRILUMINATE Pivotal Trial
Abbott Laboratories - TRISCEND II Pivotal (2020-05)
Edwards Lifesciences Corporation - ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Boston Scientific Corporation · Active, not recruiting · NCT03735667 - CLASP IIF (2018-07)
Edwards Lifesciences Corporation - Prospective, single-arm, EFS for the treatment of subjects with moderate-severe or severe symptomatic mitral valve regurgitation using the Innovalve TMVR System
Edwards Lifesciences Corporation - Edwards PASCAL Transcatheter Valve Repair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards Lifesciences Corporation - CLASP IID 2018-07
Edwards Lifesciences Corporation - Early-TAVR Trial #2016-07
Edwards Lifesciences Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.